21 U.S. Code § 1134 to 1143 - Repealed.

Section 1134,Pub. L. 92–255, title II, § 224,Mar. 21, 1972, 86 Stat. 71, provided for establishment of research and development programs by Director.
Section 1135,Pub. L. 92–255, title II, § 225,Mar. 21, 1972, 86 Stat. 72, provided for establishment of a single non-Federal share requirement.
Section 1136,Pub. L. 92–255, title II, § 226,Mar. 21, 1972, 86 Stat. 72, provided for Director to make drug prevention function recommendations to President and to consult with responsible agencies with respect to drug prevention functions.
Section 1137,Pub. L. 92–255, title II, § 227,Mar. 21, 1972, 86 Stat. 72, provided for resolution of agency conflicts with regard to drug prevention functions.
Section 1138,Pub. L. 92–255, title II, § 228,Mar. 21, 1972, 86 Stat. 72, provided for communications and liaison with respect to drug prevention functions by one of Assistant Directors.
Section 1139,Pub. L. 92–255, title II, § 229,Mar. 21, 1972, 86 Stat. 72, provided, with respect to drug prevention functions, coordination of State and local governments, availability of information and other services and activities.
Section 1140,Pub. L. 92–255, title II, § 230,Mar. 21, 1972, 86 Stat. 73, provided for a management oversight review by a Federal officer.
Section 1141,Pub. L. 92–255, title II, § 231,Mar. 21, 1972, 86 Stat. 73, provided for convening of a council of officials of Federal agencies responsible for drug prevention functions by Director.
Section 1142,Pub. L. 92–255, title II, § 232,Mar. 21, 1972, 86 Stat. 73, provided for designation of the Director to represent Government in international negotiations related to drug prevention functions.
Section 1143,Pub. L. 92–255, title II, § 233,Mar. 21, 1972, 86 Stat. 73, provided for an annual written report to the President by the Director.
Effective Date of Repeal

Section 1104 of this title, prior to repeal by Pub. L. 94–237, § 4(c)(1),Mar. 19, 1976, 90 Stat. 244, provided for repeal of sections effective June 30, 1975.

 

LII has no control over and does not endorse any external Internet site that contains links to or references LII.